Polycystic Kidney Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney Disease, Adult Interventions: Drug: Lixivaptan; Drug: Placebo Sponsor: Palladio Biosciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2019 Category: Research Source Type: clinical trials
